Testing rimegepant for migraine-time to revise the trial design?

Gasparini, Sara; Torino, Claudia; Branca, Damiano; Ferlazzo, Edoardo; Aguglia, Umberto

Gasparini, Sara; Torino, Claudia; Branca, Damiano; Ferlazzo, Edoardo; Aguglia, Umberto.

Afiliación

Gasparini S; Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Italy; Regional Epilepsy Centre, Great Metropolitan Hospital, Reggio Calabria 89100, Italy. Electronic address: s.gasparini@unicz.it.
Torino C; Consiglio Nazionale delle Ricerche-Istituto di Fisiologia Clinica, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
Branca D; Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Italy; Regional Epilepsy Centre, Great Metropolitan Hospital, Reggio Calabria 89100, Italy.
Ferlazzo E; Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Italy; Regional Epilepsy Centre, Great Metropolitan Hospital, Reggio Calabria 89100, Italy.
Aguglia U; Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Italy; Regional Epilepsy Centre, Great Metropolitan Hospital, Reggio Calabria 89100, Italy.

Lancet ; 395(10241): 1901, 2020 06 20.

Article en En | MEDLINE | ID: mdl-32563366

Asunto(s)

Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina; Trastornos Migrañosos; Método Doble Ciego; Humanos; Piperidinas; Piridinas; Comprimidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina / Trastornos Migrañosos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google